This work is licensed under a Creative Commons Attribution 4.0 International License.
General Information
DRACP ID DRACP06017
Peptide Name
Sequence DSDVWWGGRRLLRRLRRL
Sequence Length 18
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer targeted peptides Membrane-targeted Lipopeptides
Activity Information
Hemolytic Activity Low hemolysis
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification C8H15O
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C102H168N38O24
Absent amino acids ACEFHIKMNPQTY
Common amino acids R
Mass 261410
Pl 12.5
Basic residues 6
Acidic residues 2
Hydrophobic residues 7
Net charge 4
Boman Index -8010
Hydrophobicity -100
Aliphatic Index 102.78
Half Life
Mammalian: 0.8 hour
Yeast: 10 min
E.coli: >10 hour
Extinction Coefficient cystines 11000
Absorbance 280nm 647.06
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID CN114014911A
Patent Title Preparation of anti-cancer lipopeptide and application of anti-cancer lipopeptide in anti-tumor treatment
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.